表紙
市場調查報告書

C型肝炎治療的全球市場

Hepatitis C Treatment

出版商 Global Industry Analysts, Inc. 商品編碼 912543
出版日期 內容資訊 英文 155 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
C型肝炎治療的全球市場 Hepatitis C Treatment
出版日期: 2019年10月01日內容資訊: 英文 155 Pages
簡介

本報告提供全球C型肝炎治療市場調查,提供市場概要,各藥品級(HCV蛋白分解酵素抑制劑,HCV聚合酵素抑制劑,NS5A抑制劑,聯合治療,干擾素,抗病毒藥物),各地區的市場佔有率,需求趨勢,銷售額的變化與預測,市場成長要素,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲各國
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他的亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美地區
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競爭情形

  • ABBVIE
  • BRISTOL-MYERS SQUIBB COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • KADMON HOLDINGS, INC.
  • MERCK & CO., INC.

第5章 調查資料

目錄
Product Code: MCP-1858

Hepatitis C Treatment market worldwide is projected to grow by US$44.5 Billion, driven by a compounded growth of 12.9%. HCV Protease Inhibitors, one of the segments analyzed and sized in this study, displays the potential to grow at over 11.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$8.9 Billion by the year 2025, HCV Protease Inhibitors will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.8 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.5 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, HCV Protease Inhibitors will reach a market size of US$176.5 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.2% over the next couple of years and add approximately US$10.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, AbbVie, Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Johnson & Johnson; Kadmon Holdings, Inc.; Merck & Co., Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Hepatitis C Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Hepatitis C Treatment Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Hepatitis C Treatment Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Hepatitis C Treatment Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: HCV Protease Inhibitors (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: HCV Protease Inhibitors (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: HCV Protease Inhibitors (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: HCV Polymerase Inhibitors (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: HCV Polymerase Inhibitors (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: HCV Polymerase Inhibitors (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: HCV NS5A Inhibitors (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: HCV NS5A Inhibitors (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: HCV NS5A Inhibitors (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Combination Therapy (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Combination Therapy (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Combination Therapy (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Interferon & Antiviral (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Interferon & Antiviral (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Interferon & Antiviral (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Hepatitis C Treatment Market Share (in %) by Company: 2019 & 2025
    • TABLE 19: United States Hepatitis C Treatment Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 20: Hepatitis C Treatment Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 21: United States Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 22: Canadian Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 23: Canadian Hepatitis C Treatment Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 24: Hepatitis C Treatment Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • JAPAN
    • TABLE 25: Japanese Market for Hepatitis C Treatment: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 26: Hepatitis C Treatment Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 27: Japanese Hepatitis C Treatment Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 28: Chinese Hepatitis C Treatment Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 29: Hepatitis C Treatment Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
    • TABLE 30: Chinese Hepatitis C Treatment Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Hepatitis C Treatment Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 31: European Hepatitis C Treatment Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 32: Hepatitis C Treatment Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 33: European Hepatitis C Treatment Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 34: European Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 35: Hepatitis C Treatment Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 36: European Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 37: Hepatitis C Treatment Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 38: French Hepatitis C Treatment Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 39: French Hepatitis C Treatment Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 40: Hepatitis C Treatment Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 41: German Hepatitis C Treatment Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 42: German Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 43: Italian Hepatitis C Treatment Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 44: Hepatitis C Treatment Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
    • TABLE 45: Italian Hepatitis C Treatment Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Market for Hepatitis C Treatment: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 47: Hepatitis C Treatment Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 48: United Kingdom Hepatitis C Treatment Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 49: Spanish Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 50: Spanish Hepatitis C Treatment Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 51: Hepatitis C Treatment Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 52: Russian Hepatitis C Treatment Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 53: Hepatitis C Treatment Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 54: Russian Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 55: Rest of Europe Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 56: Hepatitis C Treatment Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 57: Rest of Europe Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 58: Asia-Pacific Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 59: Hepatitis C Treatment Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 60: Asia-Pacific Hepatitis C Treatment Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 61: Hepatitis C Treatment Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 62: Asia-Pacific Hepatitis C Treatment Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 63: Asia-Pacific Hepatitis C Treatment Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 64: Hepatitis C Treatment Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 65: Australian Hepatitis C Treatment Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 66: Australian Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 67: Indian Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 68: Indian Hepatitis C Treatment Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 69: Hepatitis C Treatment Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 70: Hepatitis C Treatment Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 71: South Korean Hepatitis C Treatment Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 72: Hepatitis C Treatment Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 73: Rest of Asia-Pacific Market for Hepatitis C Treatment: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 74: Hepatitis C Treatment Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 75: Rest of Asia-Pacific Hepatitis C Treatment Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 76: Latin American Hepatitis C Treatment Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 77: Hepatitis C Treatment Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 78: Latin American Hepatitis C Treatment Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 79: Latin American Hepatitis C Treatment Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 80: Hepatitis C Treatment Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
    • TABLE 81: Latin American Hepatitis C Treatment Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 82: Argentinean Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 83: Hepatitis C Treatment Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 84: Argentinean Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 85: Hepatitis C Treatment Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 86: Brazilian Hepatitis C Treatment Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 87: Brazilian Hepatitis C Treatment Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 88: Hepatitis C Treatment Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 89: Mexican Hepatitis C Treatment Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 90: Mexican Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 91: Rest of Latin America Hepatitis C Treatment Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 92: Hepatitis C Treatment Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 93: Rest of Latin America Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 94: The Middle East Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 95: Hepatitis C Treatment Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 96: The Middle East Hepatitis C Treatment Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 97: The Middle East Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 98: The Middle East Hepatitis C Treatment Historic Market by Drug Class in US$ Million: 2009-2017
    • TABLE 99: Hepatitis C Treatment Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
  • IRAN
    • TABLE 100: Iranian Market for Hepatitis C Treatment: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 101: Hepatitis C Treatment Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 102: Iranian Hepatitis C Treatment Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 103: Israeli Hepatitis C Treatment Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 104: Hepatitis C Treatment Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 105: Israeli Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 106: Saudi Arabian Hepatitis C Treatment Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 107: Hepatitis C Treatment Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
    • TABLE 108: Saudi Arabian Hepatitis C Treatment Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 109: Hepatitis C Treatment Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 110: United Arab Emirates Hepatitis C Treatment Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 111: Hepatitis C Treatment Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 112: Hepatitis C Treatment Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 113: Rest of Middle East Hepatitis C Treatment Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 114: Rest of Middle East Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 115: African Hepatitis C Treatment Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 116: Hepatitis C Treatment Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 117: African Hepatitis C Treatment Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBVIE
  • BRISTOL-MYERS SQUIBB COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • KADMON HOLDINGS, INC.
  • MERCK & CO., INC.

V. CURATED RESEARCH

Back to Top